ACIU Stock Summary and Trading Ideas (Ac Immune SA | NASDAQ:ACIU)

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Ac Immune SA trades on the NASDAQ stock market under the symbol ACIU.

As of March 20, 2026, ACIU stock price declined to $2.85 with 223,852 million shares trading.

ACIU has a beta of 1.48, meaning it tends to be more sensitive to market movements. ACIU has a correlation of 0.12 to the broad based SPY ETF.

ACIU has a market cap of $286.17 million. This is considered a Small Cap stock.

Last quarter Ac Immune SA reported $422,914 in Revenue and -$.18 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.02.

In the last 3 years, ACIU traded as high as $5.14 and as low as $1.43.

The top ETF exchange traded funds that ACIU belongs to (by Net Assets): IBB, DFAS, DFAU, DFAC, DCOR.

ACIU has outperformed the market in the last year with a price return of +28.4% while the SPY ETF gained +15.6%. However, in the short term, ACIU had mixed performance relative to the market. It has underperformed in the last 3 months, returning -5.9% vs -4.7% return in SPY. But in the last 2 weeks, ACIU shares have fared better than the market returning +4.4% compared to SPY -4.8%.

ACIU support price is $2.80 and resistance is $3.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACIU shares will trade within this expected range on the day.